of 2 pints (1 12 litres). A diagnosis of acute stress ulceration was made and the heparin was stopped. 27.3.68 (48 hours later): The patient was again started on an infusion of heparin 40,000 units/24 hours which produced effective anticoagulation for 48 hours only, when he developed heparin resistance. 29.3.68-4.4 .68: Heparin doses were increased but huge doses (up to 80,000 units/24 hours) did not produce anticoagulation and he was started on phenindione. 16.4.68: Effectively anticoagulated. Physical signs normal. Normal chest X-ray and ECG. Pulmonary angiogram and heemodynamics normal (Fig lB) . Barium meal normal. Patient now well and on phenindione only.
Comment
The treatment of massive pulmonary embolism is controversial. Some authorities (Paneth 1966) recommend surgical intervention, but others (Soloff & Rodman 1967) have stressed that 60% of patients who die from massive pulmonary embolism do so within the first thirty minutes. Death after this time is from recurrent embolism and conservative treatment is directed towards its prevention. Due to a haematemesis and later to the development of heparin resistance this patient was not effectively anticoagulated.
In cases where emboli are thought to arise in the pelvic veins vena caval plication or ligation has been recommended (Bergan et al. 1964) . Such procedures are not without their mortality and morbidity. Some observers (Gurewitch et al. 1966 ) report a 20% incidence of recurrent embolism following vena caval ligation due either to clot formation in situ or embolism via collateral vessels.
Complete, spontaneous lysis of clots in the pulmonary arteries within days or weeks as occurred in this patient has been described by others (Smith et al. 1964 ). This patient is on long-term oral anticoagulants to decrease the risk of recurrent embolism and prevent the development of pulmonary hypertension.
Dr Celia M Oakley said that this patient was not unique in completely resolving his pulmonary vascular obstruction after massive pulmonary embolism. Chronicity seems to follow flurries of emboli and complete recovery has been usual provided a patient survives the first hour or two and provided further emboli can be prevented from adding to the existing obstruction before it is removed by natural mechanisms.
This man was of interest because his recovery occurred virtually without the aid of heparin which had to be withheld during a crucial period after his hoematemesis. He was lucky in avoiding further and likely fatal embolism at this time. Inability to use anticoagulants provides perhaps the only justification for interference with the inferior vena cava. This intervention adds its own incentive to thrombosis and was considered but rejected in this patient.
Congestive Cardiac Failure due to Secondary Amyloidosis G M Shenfield MA BM (for Charles M Fletcher CBE MD) (Hammersmith Hospital, London) Mrs K B, aged 52 History: Presented in February 1968 with a story of increasing tiredness and weakness for three years, swelling of ankles for five months and exertional dyspncea for three months. She had lost about 7 lb (3-18 kg) in weight in the previous six months.
On examination: Signs of congestive cardiac failure with a disproportionately large, firm, nontender liver. No bone tenderness or splenomegaly. Tongue normal. No signs of carpal tunnel syndrome.
Investigations: Hb 14 g/100 ml, MCHC 32%, WBC 7,000 (normal differential, platelet count and film). ESR 2 mm in 1 h (Westergren). Urea, electrolytes, alkaline phosphatase, bilirubin, cholesterol and uric acid all normal. Total serum proteins 8-8, albumin 1-7 g/100 ml. Protein electrophoresis showed low albumin, raised a2-globulin with loss of normal y-globulin and a band of M paraprotein. This was typed as a yGL paraprotein (4 7 g/100 ml) with reduced yA (46 mg/100 mlnormal 125-425 mg/100 ml) and yM (13 mg/100 mlnormal 47-170 mg/100 ml). Urinary protein 15-2 g/24 h of which 25% was Bence Jones protein type L. The proteinuria was fairly highly selective (yG/transferrin clearance 0-11), a finding not uncommon with renal amyloidosis (Clinico-Pathological Conference 1968). ECG was of generalized low voltage with nonspecific T-wave inversion. X-rays: Chest: cardiac enlargement with pulmonary cedema. Skull: multiple lytic areas. Spine: partial collapse of L2 vertebra.
Bone marrow had 50% infiltration with atypical plasma cells. Rectal biopsy showed extensive infiltration with amyloid of the pericollagenic type.
A diagnosis was therefore made of yG myelomatosis with secondary amyloidosis. Biopsy evidence was obtained from the rectum and it was presumed that both the heart and kidneys were involved causing congestive cardiac failure and nephrotic syndrome. She was treated with digitalis, used carefully in view of the known risk of arrhythmias (Cohen 1967) , and with diuretics. The cedema cleared and the ESR rose to 96 mm in 1 h.
Discussionl
This patient illustrates an unusual presentation of myelomatosis although amyloidosis is a wellrecognized complication. It is said to occur in 5-10% of cases (Cohen 1967 ) but there has not been a good post-mortem series using modem techniques such as Congo red with dichroism together with paraprotein typing. However, amyloidosis is rare in association with yG myeloma and only a few cases have been described (Hobbs et al. 1966) . It is also rare to have such generalized amyloid without involvement of the tongue or evidence of carpal tunnel syndrome.
Cardiac involvement is recorded in 80% of primary, 90 % of myelomatous and 60 % of secondary amyloidosis (Cohen 1967 ) and there is a rare familial form unassociated with paraproteins (Frederiksen et al. 1962) . Microscopically there are two common distributions of cardiac amyloid: that mainly involving coronary vessels and that infiltrating throughout the epicardium, although these types may overlap. The first may be an incidental finding or may present as myocardial ischmmia or with cardiac arrhythmias. The second has the clinical picture of constrictive pericarditis with a low voltage ECG. This may also be associated with ischmmic changes and disorders of conduction. The prognosis is poor in both types and in this patient treatment of the myelomatosis, even if successful, can only hope to prevent further progression of the amyloidosis.
Dr J R Hobbs (Royal Postgraduate Medical School, London) said that this was the fifth patient seen with myelomatosis and amyloidosis of the heart, here suggested by the coincidence with nephrotic syndrome and congestive cardiac failure. Congo red could give poor results with myelomatous amyloid (Hobbs & Morgan 1963) . Using thioflavine-T, Fig 1 showed the heart of one patient with macroglossia and carpal tunnel syndrome, who had had cardiac ischemia yet only showed involvement of the coronary walls. Fig 2 showed how, in, the second and third patients, amyloid deposition had begun in the epicardium and gradually encroached on the myocardium. The fourth patient had shown the myocardial syncytium completely encased by epicardial amyloidosis, already illustrated in a similar case with primary amyloidosis (Hobbs & Morgan 1963 
